Fineotex Chemical Ltd
Fineotex Chemical Q2 FY26 earnings call: Revenue & Margins
Q2 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Fineotex targets a minimum year-on-year growth rate of 15% to 20% in sales/revenue. Fineotex has a historic CAGR growth of approximately 30% over 14 years, with nearly 40% growth in the last five years, indicating strong long-term growth potential. - The company expects a minimum year-on-year growth rate of 15-20% going forward, driven by expansion in textile, oil and gas, and newer segments like AquaStrike and water treatment. - EBITDA margins have historically ranged between 19% to 27%, averaging around 22-23%, with margins influenced by product mix and introduction of specialty products. - Recent quarters showed improved profitability: Q2 FY'26 EBITDA rose 23.12% QoQ to Rs.
From Fineotex Chemical Ltd's Q2 FY26 earnings-call transcript · updated 16 Oct 2026.
Revenue & Sales Performance
- Fineotex targets a minimum year-on-year growth rate of 15% to 20% in sales/revenue.
- Historically, the company has delivered a CAGR of 30% over 14 years, with nearly 40% growth in the last 5 years.
- Volumes have grown modestly with a 3-4% increase in the recent quarter and capacity utilization expected to ramp up in H2.
- Positive outlook on growth from newer segments like oil and gas, AquaStrike, and cleaning & hygiene with significant investments underway.
- Oil and gas segment saw an 80% QoQ growth and increased contribution from 4% to 7%-8%.
- The textile segment is expected to improve in H2 with easing geopolitical factors and improved order pipelines.
2 more points from Fineotex Chemical Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Fineotex Chemical Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The company has enhanced its production capacity to 16,000 tons, with initial utilization starting recently; more ramp-up expected in H2 FY'26 leading to better economies of scale and lower costing.
- Ongoing focus on inorganic growth: actively reviewing multiple acquisition proposals and evaluating opportunities to strengthen the portfolio and support long-term growth.
- Confident of closing good acquisition opportunities in H2 FY'26, leveraging the current softness in the global chemicals market to invest in assets and expand globally.
2 more points from Fineotex Chemical Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Fundraising & Capital Structure
See what Fineotex Chemical Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- There is a strong order pipeline, but some orders have been postponed due to geopolitical and tariff-related challenges, particularly impacting the US textile market.
- Management is confident that these postponed orders will eventually convert to revenue as the situation improves.
- The company anticipates a positive momentum in H2 FY'26, expecting better order execution.
- For the oil and gas segment, which is relatively new, management is optimistic but cautious as the gestation period for contracts is typically 2-3 years.
- AquaStrike product has received approvals, and good government orders are expected in H2 FY'26.
2 more points from Fineotex Chemical Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Fineotex Chemical Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹314 Cr, net profit ₹44 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Fineotex Chem's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Gujarat Alkalies (Q2 FY26)
2,136.64 Crores (Page 21). Key investor presentation takeaways from Gujarat Alkalies & Chemicals Ltd's Q2 FY26 investor presentation — and how it ranks against
- Platinum Industries Ltd (Q2 FY26)
Q2FY26 Revenue from Operations (Consolidated): INR 983.8 Mn, down 1% YoY from INR 996.4 Mn in Q2FY25. Key investor presentation takeaways from Platinum Industri
- Galaxy Surfactants Ltd (Q2 FY26)
Capital Work-in-Progress (CWIP) was around INR 260 crores as of FY '25. Key concall takeaways from Galaxy Surfactants Ltd's Q2 FY26 earnings call — and how it…
- Aether Industries Ltd (Q2 FY26)
EBITDA margins are sustainable at 29%-30%, supported by increasing contract manufacturing and CRAMS business. Key concall takeaways from Aether Industri.'s Q2…
Arthneeti Pro · Annual
Fineotex Chemical Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Fineotex Chemical Ltd Q2 FY26 results?
Fineotex targets a minimum year-on-year growth rate of 15% to 20% in sales/revenue. Fineotex has a historic CAGR growth of approximately 30% over 14 years, with nearly 40% growth in the last five years, indicating strong long-term growth potential. - The company expects a minimum year-on-year growth rate of 15-20% going forward, driven by expansion in textile, oil and gas, and newer segments like AquaStrike and water treatment. - EBITDA margins have historically ranged between 19% to 27%, averaging around 22-23%, with margins influenced by product mix and introduction of specialty products. - Recent quarters showed improved profitability: Q2 FY'26 EBITDA rose 23.12% QoQ to Rs.
What is Fineotex Chemical Ltd share price analysis?
Fineotex Chemical Ltd currently shows a neutral. The stock trades at a P/E of 54.5 with a market cap of ₹6,667 Cr. Investors should review the full earnings analysis for detailed insights.
Is Fineotex Chemical Ltd planning capital expenditure?
The company has enhanced its production capacity to 16,000 tons, with initial utilization starting recently; more ramp-up expected in H2 FY'26 leading to better economies of scale and lower costing.
Keep Fineotex Chemical Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.